Evolvere BioSciences
Making Next-Generation Antibiotics that Outpace Bacterial Evolution Status: Active. Batch: YC Summer 2024. HQ: Oxford, England, United Kingdom. Industry: Healthcare. https://www.evolverebiosciences.com/
Details
- city
- Oxford
- cohort year
- 2024
- country
- United Kingdom
- exited
- false
- industry
- healthcare
- one liner
- Making Next-Generation Antibiotics that Outpace Bacterial Evolution
- status
- active
- team size
- 3
accelerator → invested in1
participated in → cohort1